Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS

Ashok K. Shetty, Padmashri A. Shetty, Gabriele Zanirati, Kunlin Jin

Research output: Contribution to journalComment/debate

Original languageEnglish
Article number53
Journalnpj Regenerative Medicine
Volume6
Issue number1
DOIs
StatePublished - Dec 2021

Cite this